Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
---|
09/01/2004 | EP1451156A1 4-aminoquinoline compounds |
09/01/2004 | EP1451155A1 Compositions, methods and kits pertaining to luminescent compounds |
09/01/2004 | EP1451154A2 Inhibitors of cytosolic phospholipase a2 |
09/01/2004 | EP1450811A2 2-aryl pyrrolopyrimidines for a1 and a3 receptors |
09/01/2004 | EP1450801A2 2-aminoquinoline compounds |
09/01/2004 | EP1450795A1 Peptide isosteres containing a heterocycle useful in the treatment of alzheimer's disease |
09/01/2004 | EP1450790A2 Photosensitizing carbamate derivatives |
09/01/2004 | EP1450774A2 Chlorin photosensitizing agents for use in photodynamic therapy |
09/01/2004 | EP1347977B1 Method for the production of 2-(2-ethoxyphenyl)-substituted imidazotriazinones |
09/01/2004 | CN1525999A A compressed fluid formulation |
09/01/2004 | CN1525975A Tert. alkylphenoxy substituted polycyclic compounds |
09/01/2004 | CN1525960A Lorenz Gisela |
09/01/2004 | CN1164592C Preparing process of oxidizing and desulfurizing catalyst phthalocyanine cobalt sulfonate |
09/01/2004 | CN1164591C Hydrated forms of zilpatherol hydrochloride |
09/01/2004 | CN1164590C Imiadazodiazepine derivative |
09/01/2004 | CN1164589C Process for production of optically active pyrroloazepine derivatives |
08/31/2004 | US6784323 Enantioselective transformation of α,β-unsaturated aldehydes using chiral organic catalysts |
08/31/2004 | US6784292 Method for the production of imidazo-(1,2-C)(2,3)-benzodiazepines and intermediates in the production thereof |
08/31/2004 | US6784201 Benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake |
08/31/2004 | US6784185 Pharmaceutically active compounds |
08/31/2004 | US6784172 Acylation of 1,4-benzodiazepines, followed by nitrosation, reduction, imination with a cyclopentanone, cyclization, reduction and deacylation |
08/31/2004 | US6783753 Rapidly produces peak plasma concentrations of the compound. |
08/31/2004 | US6783557 Novel pyrazolo(1,5-a)pyrimidines comprising at least one cationic group |
08/26/2004 | WO2004072640A1 The detection and identification of saxiphilins using saxitoxin-biotin conjugates |
08/26/2004 | WO2004072243A2 Macrocyclic hepatitis c serine protease inhibitors |
08/26/2004 | WO2004072090A1 Process for preparing branched ribonucleosides from 1, 2-anhydroribofuranose intermediates |
08/26/2004 | WO2004072083A1 Benzamide derivatives as oxytocin agonists and vasopressin antagonists |
08/26/2004 | WO2004072082A1 Superphthalocyanine compounds containing six isoindole subunits ini the porphyrazine cycle, the preparation processes and uses of them |
08/26/2004 | WO2004072081A1 Certain 8-heteroaryl-6-phenyl-imidazo[1,2-a]pyrazines as modulators of kinase activity |
08/26/2004 | WO2004072080A1 Certain 8-heteroaryl-6-phenyl-imidazo[1,2-a]pyrazines as modulators of hsp90 complex activity |
08/26/2004 | WO2004072079A1 Hydrated and anhydrous sildenafil hemi-citrate compound |
08/26/2004 | WO2004072078A1 Pyrazolotriazine derivatives, methods for production and uses thereof |
08/26/2004 | WO2004072077A1 Nitrogen-substituted hexahydropyrazino[1,2-a]pyrimidine-4,7-dione derivatives, method for the production and use thereof as medicaments |
08/26/2004 | WO2004072076A1 Substituted hexahydropyrazino(1,2-a)pyrimidin-4,7-dion derivatives, method for the production and use thereof as medicaments |
08/26/2004 | WO2004072074A1 Pyrrolidinohydrochinazolines |
08/26/2004 | WO2004072064A1 Synthesis of 2-butyl-3-(2'-(1-trityl-1h-tetrazol-5-yl)biphenyl-4-yl)-1,3-diazaspirol[4,4]-non-ene-4-one |
08/26/2004 | WO2004072063A1 Heteroaryl substituted pyrolls useful as inhibitors of protein kinases |
08/26/2004 | WO2004072030A2 Process for preparing pyrrolotriazine kinase inhibitors |
08/26/2004 | WO2004072029A2 Pyrazolopyridazines useful as inhibitors of protein kinases |
08/26/2004 | WO2004071507A1 Tetracyclic pyrazole derivatives as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
08/26/2004 | WO2004071460A2 Cyclic derivatives as modulators of chemokine receptor activity |
08/26/2004 | WO2004058766A3 Tumour-inhibiting annellated azepinone derivatives |
08/26/2004 | WO2004055163A3 Substituted 1-benzoyl-3-cyano-pyrrolo[1,2-a]quinolines |
08/26/2004 | WO2004052288A3 2-nh-heteroarylimidazoles with antibacterial activity |
08/26/2004 | WO2004037212A3 Compositions comprising zopiclone derivatives and methods of making and using the same |
08/26/2004 | WO2004018438A3 Microbiocidal (e.g. fungicidal) 1,2,3-triazole derivatives |
08/26/2004 | WO2004011464A3 Novel substituted pyrazolo[1,5 a]-1,3,5-triazine derivatives and their analogues, pharmaceutical compositions containing same, use thereof as medicine and methods for preparing same |
08/26/2004 | WO2004000800A3 Electrochromic salts, solutions, and devices |
08/26/2004 | US20040167336 Octahydro-indolizine and quinolizine and hexahydro-pyrrolizine |
08/26/2004 | US20040167328 Cucurbituril-fullerene complex |
08/26/2004 | US20040167228 aerosols containing atenolol, pindolol, esmolol, propranolol, or metoprolol that are used in inhalation therapy |
08/26/2004 | US20040167201 Pyrrolidine melanocortin-specific compounds |
08/26/2004 | US20040167198 Vasculostatic agents and methods of use thereof |
08/26/2004 | US20040167157 reacting a pyridinyl ketone with a halogenating agent in acetonitrile and dimethylformamide; hydrolysis, animation to get a 3-amino 4-halo pyridine; chemical intermediate; by-product inhibition |
08/26/2004 | US20040167145 moderator of cholinergic agent; mixture of acetylcholinesterase inhibitors and opioiod receptor blockers |
08/26/2004 | US20040167141 Anticancer agents; antidiabetic agents; Alzheimer's disease |
08/26/2004 | US20040167138 Antiischemic agents; brain disorders |
08/26/2004 | US20040167136 Substituted 6-(2-methoxyphenyl) triazolopyrimides as fungicides |
08/26/2004 | US20040167133 Beta-amino tetrahydroimidazo (1, 2-a) pyrazines and tetrahydrotrioazolo (4,3-a) pyrazines as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
08/26/2004 | US20040167124 Viricides; immunology moderator |
08/26/2004 | US20040167106 Prevention of ovarian cancer by administration of a Vitamin D compound |
08/26/2004 | US20040167031 Arylphenyl-substituted cyclic ketoenols |
08/26/2004 | US20040164294 Organic thin film transistor |
08/26/2004 | DE10305885A1 New pyrazinopyrimidine or pyrazinoimidazole derivatives useful for weight reduction in mammals, for preventing or treating obesity, type II diabetes or metabolic syndrome and for treating sexual disorders |
08/26/2004 | DE10304141A1 Verfahren zur Herstellung von Chinazolin-Alkaloiden Process for the preparation of quinazoline alkaloids |
08/26/2004 | CA2640585A1 Synthesis of 2-butyl-3-(2'-(1-trityl-1h-tetrazol-5-yl)biphenyl-4-yl)-1,3-diazaspirol{4,4}-non-ene-4-one |
08/26/2004 | CA2519018A1 The detection and identification of saxiphilins using saxitoxin-biotin conjugates |
08/26/2004 | CA2516254A1 Tetracyclic pyrazole derivatives as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
08/26/2004 | CA2515735A1 Substituted hexahydropyrazino(1,2-a)pyrimidin-4,7-dion derivatives, method for the production and use thereof as medicaments |
08/26/2004 | CA2515218A1 Process for preparing pyrrolotriazine kinase inhibitors |
08/26/2004 | CA2515216A1 Macrocyclic hepatitis c serine protease inhibitors |
08/26/2004 | CA2515138A1 Synthesis of 2-butyl-3-(2'-(1-trityl-1h-tetrazol-5-yl)biphenyl-4-yl)-1,3-diazaspirol[4,4]-non-ene-4-one |
08/26/2004 | CA2514791A1 Nitrogen-substituted hexahydropyrazino[1,2-a]pyrimidine-4,7-dione derivatives, method for the production and use thereof as medicaments |
08/26/2004 | CA2513220A1 Benzamide derivatives as oxytocin agonists and vasopressin antagonists |
08/25/2004 | EP1449844A1 benzamide derivatives as oxytocin agonists and vasopressin antagonists |
08/25/2004 | EP1449843A1 Intermediates for the preparation of carbamoyl tetrahydropyridine derivatives |
08/25/2004 | EP1449835A2 Alpha-substituted pyrimidine-thioalkyl and alkylether compounds |
08/25/2004 | EP1449833A1 Bisimide compound, acid generator and resist composition each containing the same, and method of forming pattern from the composition |
08/25/2004 | EP1449529A1 Protein Kinase C Inhibitors |
08/25/2004 | EP1448565A1 ADENOSINE A?2a? RECEPTOR ANTAGONISTS |
08/25/2004 | EP1448564A2 Substituted indolizine-like compounds and methods of use |
08/25/2004 | EP1448546A1 Novel mono- and di-fluorinated benzothiepine compounds as inhibitors of apical sodium co-dependent bile acid transport (asbt) and taurocholate uptake |
08/25/2004 | EP1448525A1 Novel piperidine derivatives as modulators of chemokine receptors |
08/25/2004 | EP1381610B1 6-(2-chloro-6-fluoro-phenyl)-triazolopyrimidines |
08/25/2004 | EP1353750B1 Stable free nitroxyl radicals as oxidation catalysts and process for oxidation |
08/25/2004 | CN1524083A Method for selectively synthesising triethylenediamine |
08/25/2004 | CN1524082A Beta-amino tetrahydroimidazo (1,2-a) pyrazines and ahydrotrioazolo (4,3-a) pyrazines as dipeptidyl idase inhibitors for the treatment or prevention of diabetes |
08/25/2004 | CN1524081A Pyrimidine derivatives for inhibition of cell proliferation |
08/25/2004 | CN1524080A Phthalatyinone-piperidino-derivatives as pde4 inhibitors |
08/25/2004 | CN1523019A Tricyclic triazolobenzazepine derivatives, process for producing the same, and antiallergic agents |
08/25/2004 | CN1522701A Epoxy-steroidal aldosterone antagonist and angiotensin ii antagonist combination therapy |
08/25/2004 | CN1163489C Human gamma globulin affinity ligand and its use |
08/25/2004 | CN1163224C Drugs for improving vesical excretory capacity |
08/25/2004 | CN1163143C Fungicide mixture |
08/24/2004 | US6781001 Extended rhodamine dye compound suitable for the creating of sets of spactrally resolvable fluorescent labels particlularly useful for fluorescence based dna sequencing system |
08/24/2004 | US6780993 Useful as inhibitors for 5'-deoxy-5'- methylthioadenosine phosphorylase (mtap)and in treating cancers |
08/24/2004 | US6780875 Quinoline-4-carboxamide derivatives as NK-3 and NK-2 receptor antagonists |
08/24/2004 | US6780862 Such as amino-indazoles for treatment of central nervous system disorders |
08/24/2004 | US6780400 Delivery of antiemetics through an inhalation route |
08/24/2004 | US6780399 Delivery of stimulants through an inhalation route |